EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Hmong microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C): A phase II clinical study protocol

Ya-Feng Wen, Kathleen A Culhane-Pera, Shannon L Pergament, Yeng Moua, Bai Vue, Toua Yang, Muaj Lo, Boguang Sun iD, Dan Knights, Robert J Straka iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0279830 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2023. Verfasst von Ya-Feng Wen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, United States of America. Hauptthemen laut MEDLINE: Hyperuricemia, COVID-19, Gout, Microbiota. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, University of Minnesota Clinical, Translational Science Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hmong men in Minnesota exhibit a high prevalence of gout and hyperuricemia. Although evidence of vitamin C’s effectiveness as a treatment for gout is mixed, analysis of therapeutic benefit based on an individual’s multiomic signature may identify predictive markers of treatment success.

Objectives

The primary objective of the H mong M icrobiome AN d G out, O besity, Vitamin C (HMANGO-C) study was to assess the effectiveness of vitamin C on serum urate in Hmong adults with and without gout/hyperuricemia. The secondary objectives were to assess if 1) vitamin C impacts the taxonomic and functional patterns of microbiota; 2) taxonomic and functional patterns of microbiota impact vitamin C’s urate-lowering effects; 3) genetic variations impact vitamin C’s urate-lowering effects; 4) differential microbial biomarkers exist for patients with or without gout; and 5) there is an association between obesity, gut microbiota and gout/hyperuricemia.

Methods

This prospective open-labelled clinical trial was guided by community-based participatory research principles and conducted under research safety restrictions for SARS-CoV-2. We aimed to enroll a convenient sample of 180 Hmong adults (120 with gout/hyperuricemia and 60 without gout/hyperuricemia) who provided medical, demographic, dietary and anthropometric information. Participants took vitamin C 500mg twice daily for 8 weeks and provided pre-and post- samples of blood and urine for urate measurements as well as stool samples for gut microbiome. Salivary DNA was also collected for genetic markers relevant to uric acid disposition. Expected results We expected to quantify the impact of vitamin C on serum urate in Hmong adults with and without gout/hyperuricemia. The outcome will enhance our understanding of how gut microbiome and genomic variants impact the urate-lowering of vitamin C and associations between obesity, gut microbiota and gout/hyperuricemia. Ultimately, findings may improve our understanding of the causes and potential interventions that could be used to address health disparities in the prevalence and management of gout in this underserved population.

Trial registration

ClinicalTrials.gov NCT04938024 (first posted: 06/24/2021).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaCOVID-19GoutMicrobiotaMaleAdultHumansUric AcidAscorbic AcidProspective StudiesSARS-CoV-2Gout SuppressantsObesityVitaminsClinical Trials, Phase II as Topic

Substanzen

Uric AcidAscorbic AcidGout SuppressantsVitamins

Autor:innen und Institutionen

  • Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, United States of America.
  • Minnesota Community Care, St. Paul, Minnesota, United States of America.
  • SoLaHmo Partnership for Health and Wellness, Community-University Health Care Center, Minneapolis, Minnesota, United States of America.
  • Bioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, Minnesota, United States of America.
  • Biotechnology Institute, University of Minnesota, Minneapolis, Minnesota, United States of America.
  • Department of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota, United States of America.

ORCID-Profile: Boguang Sun, Robert J Straka

Förderung

  • NCATS NIH HHS
  • University of Minnesota Clinical
  • Translational Science Institute
  • the Graduate School at the University of Minnesota
  • University of Minnesota
  • National Institutes of Health’s National Center for Advancing Translational Sciences

Zitieren

APA

Wen, Y. F., Culhane-Pera, K. A., Pergament, S. L., Moua, Y., Vue, B., Yang, T., Lo, M., Sun, B., Knights, D., & Straka, R. J. (2023). Hmong microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C): A phase II clinical study protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0279830

Vancouver

Wen YF, Culhane-Pera KA, Pergament SL, Moua Y, Vue B, Yang T, et al. Hmong microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C): A phase II clinical study protocol. PLOS ONE. 2023. doi:10.1371/journal.pone.0279830

BibTeX
@article{Wen2023,
  author = {Wen, Ya-Feng and Culhane-Pera, Kathleen A and Pergament, Shannon L and Moua, Yeng and Vue, Bai and Yang, Toua and Lo, Muaj and Sun, Boguang and Knights, Dan and Straka, Robert J},
  title = {Hmong microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C): A phase II clinical study protocol},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0279830}
}
Kostenlos starten →